116 related articles for article (PubMed ID: 38241069)
1. Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines.
Severin O; Pilyo S; Kachaeva M; Zhirnov V; Hodyna D; Bahrieieva O; Brovarets V
ChemMedChem; 2024 Mar; 19(5):e202300527. PubMed ID: 38241069
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Anticancer Activity of 1,3-Oxazol-4-ylphosphonium Salts in Vitro.
Brusnakov M; Golovchenko O; Velihina Y; Liavynets O; Zhirnov V; Brovarets V
ChemMedChem; 2022 Oct; 17(20):e202200319. PubMed ID: 36037305
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole-Incorporated Naphthyridine Derivatives.
Rangaswamy S; Sreenivasulu R; Babu VR; Syed T; Kapavarapu RK; Jayaprakash HV; Abbaraju VDNK
Chem Biodivers; 2023 Dec; 20(12):e202300466. PubMed ID: 37864549
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Anticancer Activities and Molecular Docking Studies of a Novel Class of 2-Phenyl-5,6,7,8-tetrahydroimidazo [1,2-
Bourzikat O; El Abbouchi A; Ghammaz H; El Brahmi N; El Fahime E; Paris A; Daniellou R; Suzenet F; Guillaumet G; El Kazzouli S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014478
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
7. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.
Zaraei SO; Al-Ach NN; Anbar HS; El-Gamal R; Tarazi H; Tokatly RT; Kalla RR; Munther MA; Wahba MM; Alshihabi AM; Shehata MK; Sbenati RM; Shahin AI; El-Awady R; Al-Tel TH; El-Gamal MI
Eur J Med Chem; 2022 Aug; 238():114434. PubMed ID: 35551038
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization, and Biological Study of 3-Trifluoromethylpyrazole Tethered Chalcone-Pyrrole and Pyrazoline-Pyrrole Derivatives.
Kisan Rasal N; Bhaskar Sonawane R; Vijay Jagtap S
Chem Biodivers; 2021 Oct; 18(10):e2100504. PubMed ID: 34409724
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of 5-chloro-6-methylaurone derivatives as potential anti-cancer agents.
Lone MS; Nabi SA; Wani FR; Garg M; Amin S; Samim M; Shafi S; Khan F; Javed K
J Biomol Struct Dyn; 2023; 41(22):13466-13487. PubMed ID: 36856061
[TBL] [Abstract][Full Text] [Related]
15. Sulphonamido-quinoxalines: search for anticancer agent.
Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Characterization and in vitro Anticancer Evaluation of 5-Sulfinyl(sulfonyl)-4-arylsulfonyl-Substituted 1,3-Oxazoles.
Zyabrev V; Pilyo S; Demydchuk B; Kachaeva M; Semenyuta I; Zhirnov V; Velihina Y; Brovarets V
ChemMedChem; 2023 Jul; 18(14):e202300161. PubMed ID: 37169720
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
Sławiński J; Brzozowski Z
Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
[TBL] [Abstract][Full Text] [Related]
19. New 2-[(4-Amino-6-
Tomorowicz Ł; Żołnowska B; Szafrański K; Chojnacki J; Konopiński R; Grzybowska EA; Sławiński J; Kawiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806186
[TBL] [Abstract][Full Text] [Related]
20. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFR
Raghunath Khedkar N; Sindkhedkar M; Joseph A
Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
